Team

Building tomorrow’s immunotherapies with proven scientific and strategic leadership.

Founder

The originator of MABPRO’s mission, combining science and purpose to pioneer new solutions for patients with aggressive cancers.

Jaromír Pastorek

Founder & Chief Scientific Officer

Former SAS President, CA IX co-discoverer, virologist with 40+ years in science, research leadership, and academic innovation in Slovakia.

Full Profile

Board

Leaders with business, clinical, and biotech experience working together to bring breakthrough therapies to life.

Jaroslav Rezník

Chairman of the Board of Management

Jaroslav Rezník is an experienced media executive and strategist, leading major projects and bringing results-driven leadership to MABPRO, a.s. since 2024.

Full Profile

Roman Korbačka

Member of the Board of Directors

Roman Korbačka is a Slovak entrepreneur and investor active in real estate, banking, and strategic projects with J&T, with a background in technical cybernetics.

Full Profile

Marek Paščák

General Director

Marek Paščák is an experienced leader who spent 25 years at DATALAN, driving growth, innovation, and connecting business with research and academia.

Full Profile

Viliam Janáč

Chief Legal Officer

Head of the corporate legal department responsible for legal affairs and proper maintaining of corporate interactions with EMA and relevant state governmental bodies.

Full Profile

Richard Imrich

Vice President Clinical Research

Richard has 25+ years of experience in clinical research and drug development. He is former director of NIRD and ex-vice-president of the Slovak Academy of Sciences.

Full Profile

Scientific Advisory Board

Trusted scientific and industry experts helping steer our research with evidence-based insight and global perspective.

Adrian Harris

Board Member

Professor of Medical Oncology at Oxford, CRUK lab director, journal editor, and leading cancer researcher involved in major UK institutions and initiatives.

Full Profile

Silvia Pastoreková

Board Member

Professor Silvia Pastoreková, Director of BMC SAS, co-discovered CA9, a key cancer biomarker, and is the first Slovak EMBO member with 300+ publications.

Full Profile

Cancer Immunotherapy Platform For Hypoxic Tumors

Management Advisory Board

A team of experienced leaders providing strategic insight, scientific expertise, and business guidance to support the growth and innovation of the company.